Emily McCullagh

589 total citations
8 papers, 429 citations indexed

About

Emily McCullagh is a scholar working on Hematology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Emily McCullagh has authored 8 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Oncology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Emily McCullagh's work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Emily McCullagh is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Emily McCullagh collaborates with scholars based in United States and United Kingdom. Emily McCullagh's co-authors include Lalit Kalra, Gavin Brigstocke, Nora Donaldson, Joseph D Tariman, Heather Landau, Maria Gavino, Elizabeth Bilotti, Lisa C. Smith, Kathleen Colson and K Lilleby and has published in prestigious journals such as Blood, Annals of Internal Medicine and Stroke.

In The Last Decade

Emily McCullagh

8 papers receiving 397 citations

Peers

Emily McCullagh

REHAB

PMH

EPIDE

GHP

CP

Joan Wasserman United States

Paolo Meucci Italy

Grażyna Bączyk Poland

Katherine Knox Canada

John C. Friel United States

Nancy J. Walker United States

Marianne E. Klinke Iceland

Amy Webster United Kingdom

A. Reusch Germany

Helena Correia United States

Joan Wasserman United States

Emily McCullagh

144 ×0.7

REHAB

84 ×0.4

PMH

105 ×0.9

EPIDE

81 ×0.9

GHP

29 ×0.3

CP

Citations per year, relative to Emily McCullagh Emily McCullagh (= 1×) peers Joan Wasserman

Countries citing papers authored by Emily McCullagh

Since Specialization

Citations

This map shows the geographic impact of Emily McCullagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily McCullagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily McCullagh more than expected).

Fields of papers citing papers by Emily McCullagh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily McCullagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily McCullagh. The network helps show where Emily McCullagh may publish in the future.

Co-authorship network of co-authors of Emily McCullagh

This figure shows the co-authorship network connecting the top 25 collaborators of Emily McCullagh. A scholar is included among the top collaborators of Emily McCullagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily McCullagh. Emily McCullagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Adel, Nelly G., Emily McCullagh, Lilian Reich, et al.. (2011). Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC),. Blood. 118(21). 4059–4059. 3 indexed citations

2.

Landau, Heather, Hani Hassoun, Adam D. Cohen, et al.. (2009). Adjuvant Bortezomib and Dexamethasone Following Risk-Adapted Melphalan and Stem Cell Transplant in Systemic Light-Chain Amyloidosis (AL): A Phase II Study.. Blood. 114(22). 533–533. 4 indexed citations

3.

Bilotti, Elizabeth, Kathleen Colson, Kathleen M. Curran, et al.. (2008). Management of Side Effects of Novel Therapies for Multiple Myeloma: Consensus Statements Developed by the International Myeloma Foundation's Nurse Leadership Board. Clinical journal of oncology nursing. 12(0). 9–12. 13 indexed citations

4.

Tariman, Joseph D, et al.. (2008). Peripheral Neuropathy Associated With Novel Therapies in Patients With Multiple Myeloma: Consensus Statement of the IMF Nurse Leadership Board. Clinical journal of oncology nursing. 12(0). 29–35. 35 indexed citations

5.

Small, Trudy N., Robert D. Rice, Emily McCullagh, et al.. (2007). Vaccine Efficacy Following Autologous Peripheral Blood Stem Cell Transplant for Lymphoma.. Blood. 110(11). 603–603. 4 indexed citations

6.

McCullagh, Emily, Gavin Brigstocke, Nora Donaldson, & Lalit Kalra. (2005). Determinants of Caregiving Burden and Quality of Life in Caregivers of Stroke Patients. Stroke. 36(10). 2181–2186. 354 indexed citations

7.

McCullagh, Emily. (1956). ON THE CHOICE OF TREATMENT FOR HYPERTHYROIDISM. Annals of Internal Medicine. 44(2). 292–301. 5 indexed citations

8.

McCullagh, Emily. (1952). RADIOACTIVE IODINE IN THE TREATMENT OF HYPERTHYROIDISM. Annals of Internal Medicine. 37(4). 739–744. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact